Fintepla (fenfluramine) is an oral solution used to treat seizures from certain epilepsy conditions. It’s typically taken twice daily. Specific doses are based on body weight and calculated by ...

The agency announced on February 24 that it no longer expected prescribers, pharmacies, and patients to participate in the risk evaluation and mitigation strategies (REMS) program or to report ...

The REMS, originally designed to reduce the risk of clozapine-related neutropenia, has instead created substantial and avoidable barriers to basic care. As part of this REMS program, prescribers ...

In a U-turn for the UK health technology assessor, the National Institute for Health and Care Excellence (NICE) has today approved Fintepla (fenfluramine) for the treatment of Lennox-Gastaut syndrome ...

The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...

There’s also “an open question whether zorevunersen can garner rare disease level pricing” in non-U.S. markets, given that other seizure medicines like Epidiolex and Fintepla have struggled.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.